|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
EXP ISO |
tanshinone inhibits the reaction [Rifampin results in decreased expression of ABCB11 mRNA]; tanshinone inhibits the reaction [Rifampin results in decreased expression of ABCB11 protein] tanshinone inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid] |
CTD |
PMID:35101544 PMID:35544702 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC2 mRNA; [tanshinone co-treated with Acetaminophen] results in increased expression of ABCC2 protein; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC2 mRNA]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC2 protein] |
CTD |
PMID:35243748 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
ISO |
[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 mRNA; [tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 protein [tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 mRNA; [tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 protein; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 mRNA]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 protein] |
CTD |
PMID:35243748 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
increases expression |
ISO |
tanshinone results in increased expression of ACADVL mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression |
ISO |
tanshinone results in increased expression of ACSL1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP ISO |
tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] |
CTD |
PMID:32097614 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
tanshinone binds to and results in increased activity of AHR protein; tanshinone promotes the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA] |
CTD |
PMID:21262253 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
EXP |
Fulvestrant inhibits the reaction [tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased phosphorylation of AKT1 protein]]; tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased phosphorylation of AKT1 protein] tanshinone results in increased phosphorylation of AKT1 protein |
CTD |
PMID:34655285 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
decreases expression |
ISO |
tanshinone results in decreased expression of ALDH1A3 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
decreases expression |
ISO |
tanshinone results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Apoc1 |
apolipoprotein C1 |
increases expression |
ISO |
tanshinone results in increased expression of APOC1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apom |
apolipoprotein M |
increases expression |
ISO |
tanshinone results in increased expression of APOM mRNA |
CTD |
PMID:15849732 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
Aqp9 |
aquaporin 9 |
multiple interactions |
ISO |
[[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide; [[tetraarsenic tetrasulfide co-treated with tanshinone] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide; [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein]; [tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein; tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA]; tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] |
CTD |
PMID:18344322 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
ISO |
tanshinone results in decreased expression of ASNS mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
decreases expression |
ISO |
tanshinone results in decreased expression of ASS1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atp6v0b |
ATPase H+ transporting V0 subunit B |
increases expression |
ISO |
tanshinone results in increased expression of ATP6V0B mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 5:131,423,384...131,424,900
Ensembl chr 5:131,423,387...131,426,401
|
|
G |
Atp6v1e1 |
ATPase H+ transporting V1 subunit E1 |
increases expression |
ISO |
tanshinone results in increased expression of ATP6V1E1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 4:154,022,358...154,044,486
Ensembl chr 4:154,022,358...154,044,584
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
EXP |
tanshinone promotes the reaction [IGF2 protein mutant form results in increased expression of BAD protein] |
CTD |
PMID:34655285 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
tanshinone results in increased expression of BAX protein |
CTD |
PMID:21699893 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
ISO |
tanshinone results in decreased expression of BCKDHB mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
tanshinone results in decreased expression of BCL2 protein |
CTD |
PMID:16009009 PMID:19885617 PMID:20369472 PMID:21699893 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
tanshinone results in decreased expression of BIRC3 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression multiple interactions |
ISO |
tanshinone results in decreased expression of BIRC5 mRNA SB 203580 inhibits the reaction [tanshinone results in decreased expression of BIRC5 mRNA]; tanshinone inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] |
CTD |
PMID:21165580 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Calcoco2 |
calcium binding and coiled-coil domain 2 |
increases expression |
ISO |
tanshinone results in increased expression of CALCOCO2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:81,055,467...81,069,298
|
|
G |
Casp3 |
caspase 3 |
increases expression increases activity multiple interactions |
ISO EXP |
tanshinone results in increased expression of CASP3 protein tanshinone results in increased activity of CASP3 protein Fulvestrant inhibits the reaction [tanshinone inhibits the reaction [IGF2 protein mutant form results in increased cleavage of CASP3 protein]]; tanshinone inhibits the reaction [IGF2 protein mutant form results in increased cleavage of CASP3 protein] |
CTD |
PMID:15849732 PMID:21699893 PMID:34655285 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
tanshinone promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] |
CTD |
PMID:26203587 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
tanshinone inhibits the reaction [Particulate Matter results in increased expression of CCND1 protein] |
CTD |
PMID:35304817 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd33 |
CD33 molecule |
decreases expression |
ISO |
tanshinone results in decreased expression of CD33 protein |
CTD |
PMID:16009009 |
|
NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions decreases expression |
ISO |
15-deoxyprostaglandin J2 inhibits the reaction [tanshinone results in decreased expression of CD36 mRNA]; tanshinone inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of CD36 mRNA]; tanshinone inhibits the reaction [Troglitazone results in increased expression of CD36 mRNA]; Troglitazone inhibits the reaction [tanshinone results in decreased expression of CD36 mRNA] tanshinone results in decreased expression of CD36 mRNA; tanshinone results in decreased expression of CD36 protein |
CTD |
PMID:20854809 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd68 |
Cd68 molecule |
decreases expression |
ISO |
tanshinone results in decreased expression of CD68 protein |
CTD |
PMID:20854809 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[Doxorubicin co-treated with tanshinone] affects the expression of CDH1 protein; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in decreased expression of CDH1 protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in decreased expression of CDH1 protein]; WAY-262611 affects the reaction [[Doxorubicin co-treated with tanshinone] affects the expression of CDH1 protein] |
CTD |
PMID:32097614 PMID:32886829 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[tanshinone co-treated with indirubin] promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of CDK2 protein]; [tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased expression of CDK2 protein] |
CTD |
PMID:18344322 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
tanshinone results in increased expression of CDKN1A mRNA |
CTD |
PMID:15849732 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions increases expression |
ISO |
indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]]; indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein]; tanshinone promotes the reaction [indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]]; tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]; tetraarsenic tetrasulfide promotes the reaction [indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein]] |
CTD |
PMID:18344322 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Ceacam6 |
CEA cell adhesion molecule 6 |
decreases expression |
ISO |
tanshinone results in decreased expression of CEACAM6 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:80,416,531...80,434,668
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions increases expression |
ISO |
[indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPA protein]; [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPA protein] |
CTD |
PMID:18344322 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression multiple interactions |
ISO |
tanshinone results in increased expression of CEBPB protein [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPB protein]; [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPB protein] |
CTD |
PMID:18344322 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions increases expression |
ISO |
[indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPE protein]; [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPE protein] |
CTD |
PMID:18344322 |
|
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
tanshinone results in increased expression of CFLAR protein |
CTD |
PMID:26203587 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Clu |
clusterin |
increases expression |
ISO |
tanshinone results in increased expression of CLU mRNA |
CTD |
PMID:15849732 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
decreases expression |
ISO |
tanshinone results in decreased expression of COL6A1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Cst6 |
cystatin E/M |
increases expression |
ISO |
tanshinone results in increased expression of CST6 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression multiple interactions |
ISO |
tanshinone results in increased expression of CTNNB1 mRNA [Doxorubicin co-treated with tanshinone] affects the expression of CTNNB1 protein; WAY-262611 affects the reaction [[Doxorubicin co-treated with tanshinone] affects the expression of CTNNB1 protein] |
CTD |
PMID:25186638 PMID:32886829 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
tanshinone promotes the reaction [IGF2 protein mutant form results in increased expression of CYCS protein] |
CTD |
PMID:34655285 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
tanshinone results in increased expression of CYP1A1 mRNA; tanshinone results in increased expression of CYP1A1 protein Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A1 mRNA]; tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] |
CTD |
PMID:15849732 PMID:16955220 PMID:21262253 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression multiple interactions |
ISO |
tanshinone results in increased expression of CYP1A2 mRNA; tanshinone results in increased expression of CYP1A2 protein Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA]; tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] |
CTD |
PMID:21262253 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
ISO |
tanshinone results in decreased activity of CYP2C19 protein |
CTD |
PMID:25686904 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity |
ISO |
tanshinone results in decreased activity of CYP2C8 protein |
CTD |
PMID:29689254 |
|
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression |
ISO |
NR1I2 protein promotes the reaction [tanshinone results in increased expression of CYP3A4 protein]; NR1I3 protein affects the reaction [tanshinone results in increased expression of CYP3A4 protein]; NR3C1 protein affects the reaction [tanshinone results in increased expression of CYP3A4 protein] |
CTD |
PMID:18805405 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dck |
deoxycytidine kinase |
increases expression |
ISO |
tanshinone results in increased expression of DCK mRNA |
CTD |
PMID:15849732 |
|
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
[TNFSF10 protein co-treated with tanshinone] results in increased expression of DDIT3 protein; Acetylcysteine inhibits the reaction [tanshinone results in increased expression of DDIT3 protein]; DDIT3 mutant form inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; DDIT3 mutant form inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased expression of TNFRSF10B protein]; pyrazolanthrone inhibits the reaction [tanshinone results in increased expression of DDIT3 protein] tanshinone results in increased expression of DDIT3 mRNA; tanshinone results in increased expression of DDIT3 protein |
CTD |
PMID:26203587 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
tanshinone analog inhibits the reaction [Lipopolysaccharides results in decreased expression of DUSP1 protein] |
CTD |
PMID:29906494 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
increases expression |
ISO |
tanshinone results in increased expression of DUSP11 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
tanshinone results in increased expression of DUSP5 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dyrk4 |
dual specificity tyrosine phosphorylation regulated kinase 4 |
decreases expression |
ISO |
tanshinone results in decreased expression of DYRK4 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
tanshinone inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 protein] |
CTD |
PMID:28985491 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
EXP |
tanshinone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein] |
CTD |
PMID:28985491 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of EDNRB protein] |
CTD |
PMID:28985491 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
decreases response to substance decreases expression |
ISO |
ELK1 mRNA results in decreased susceptibility to tanshinone tanshinone results in decreased expression of ELK1 mRNA |
CTD |
PMID:30506648 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
increases expression |
ISO |
tanshinone results in increased expression of ENC1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
decreases expression multiple interactions |
ISO |
tanshinone results in decreased expression of ERCC1 mRNA SB 203580 inhibits the reaction [tanshinone results in decreased expression of ERCC1 mRNA] |
CTD |
PMID:21165580 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
tanshinone results in decreased expression of ETS2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
increases expression |
ISO |
tanshinone results in increased expression of F2RL1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
|
|
G |
Flad1 |
flavin adenine dinucleotide synthetase 1 |
increases expression |
ISO |
tanshinone results in increased expression of FLAD1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 2:174,819,451...174,828,921
Ensembl chr 2:174,819,453...174,828,977
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO EXP |
NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of FN1 protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of FN1 protein] |
CTD |
PMID:32097614 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
tanshinone results in increased expression of FOS protein |
CTD |
PMID:16009009 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gba1 |
glucosylceramidase beta 1 |
increases expression |
ISO |
tanshinone results in increased expression of GBA1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 2:174,609,437...174,615,457
Ensembl chr 2:174,609,403...174,618,263
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
ISO |
tanshinone results in increased expression of GFAP mRNA; tanshinone results in increased expression of GFAP protein |
CTD |
PMID:16955220 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gnaq |
G protein subunit alpha q |
multiple interactions |
EXP |
[tanshinone co-treated with Fulvestrant] inhibits the reaction [IGF2 protein mutant form results in increased expression of GNAQ protein] |
CTD |
PMID:34655285 |
|
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
tanshinone inhibits the reaction [Lithocholic Acid results in increased expression of GPT protein] |
CTD |
PMID:36804361 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
increases expression |
ISO |
tanshinone results in increased expression of GRB7 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases expression |
ISO |
tanshinone results in decreased expression of GSK3B mRNA |
CTD |
PMID:25186638 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
tanshinone results in decreased expression of GSTP1 mRNA |
CTD |
PMID:21165580 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
multiple interactions |
ISO |
[tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased phosphorylation of H1F2 protein]; tanshinone promotes the reaction [indirubin results in decreased phosphorylation of H1F2 protein] |
CTD |
PMID:18344322 |
|
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[tanshinone co-treated with indirubin] inhibits the reaction [RARB protein binds to HDAC1 protein]; [tetraarsenic tetrasulfide co-treated with tanshinone] inhibits the reaction [RARB protein binds to HDAC1 protein]; indirubin promotes the reaction [[tetraarsenic tetrasulfide co-treated with tanshinone] inhibits the reaction [RARB protein binds to HDAC1 protein]]; tetraarsenic tetrasulfide promotes the reaction [[tanshinone co-treated with indirubin] inhibits the reaction [RARB protein binds to HDAC1 protein]] |
CTD |
PMID:18344322 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac3 |
histone deacetylase 3 |
increases expression |
ISO |
tanshinone results in increased expression of HDAC3 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
EXP ISO |
tanshinone results in increased expression of HMOX1 protein tanshinone promotes the reaction [Silicon Dioxide results in increased expression of HMOX1 protein] |
CTD |
PMID:19356721 PMID:32097614 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
tanshinone results in increased expression of ID2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
EXP |
[Fulvestrant co-treated with tanshinone] promotes the reaction [IGF2 protein mutant form results in increased expression of PPP3CA protein]; [IGF2 protein mutant form co-treated with tanshinone] results in decreased expression of IGF2R protein; [tanshinone co-treated with Fulvestrant] inhibits the reaction [IGF2 protein mutant form results in increased expression of GNAQ protein]; Fulvestrant inhibits the reaction [tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased expression of PIK3R1 protein]]; Fulvestrant inhibits the reaction [tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased phosphorylation of AKT1 protein]]; Fulvestrant inhibits the reaction [tanshinone inhibits the reaction [IGF2 protein mutant form results in increased cleavage of CASP3 protein]]; tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased expression of PIK3R1 protein]; tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased phosphorylation of AKT1 protein]; tanshinone inhibits the reaction [IGF2 protein mutant form results in increased cleavage of CASP3 protein]; tanshinone promotes the reaction [IGF2 protein mutant form results in increased expression of BAD protein]; tanshinone promotes the reaction [IGF2 protein mutant form results in increased expression of CYCS protein]; tanshinone promotes the reaction [IGF2 protein mutant form results in increased expression of PPP3CA protein] |
CTD |
PMID:34655285 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
multiple interactions decreases expression |
EXP |
[IGF2 protein mutant form co-treated with tanshinone] results in decreased expression of IGF2R protein tanshinone results in decreased expression of IGF2R protein |
CTD |
PMID:34655285 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
tanshinone inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA] |
CTD |
PMID:30098273 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; tanshinone inhibits the reaction [Particulate Matter results in increased expression of IL6 protein] tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:29906494 PMID:35304817 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
decreases activity |
ISO |
tanshinone results in decreased activity of IMPDH2 protein |
CTD |
PMID:37871880 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
increases expression |
ISO |
tanshinone results in increased expression of INPPL1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:156,183,043...156,197,500
Ensembl chr 1:156,183,059...156,197,500
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
increases expression |
ISO |
tanshinone results in increased expression of ISG20 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Itga6 |
integrin subunit alpha 6 |
decreases expression |
ISO |
tanshinone results in decreased expression of ITGA6 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
ISO |
tanshinone results in increased expression of ITGAM protein |
CTD |
PMID:16009009 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
tanshinone promotes the reaction [Silicon Dioxide results in decreased expression of KEAP1 protein] |
CTD |
PMID:32097614 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases response to substance decreases expression |
ISO |
KRAS mRNA results in decreased susceptibility to tanshinone tanshinone results in decreased expression of KRAS mRNA; tanshinone results in decreased expression of KRAS protein |
CTD |
PMID:30506648 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
decreases expression multiple interactions |
ISO |
tanshinone results in decreased expression of LRP1 mRNA SB 203580 inhibits the reaction [tanshinone results in decreased expression of LRP1 mRNA]; tanshinone inhibits the reaction [Cisplatin results in increased expression of LRP1 mRNA] |
CTD |
PMID:21165580 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
decreases expression |
ISO |
tanshinone results in decreased expression of LRP5 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:200,814,247...200,917,581
Ensembl chr 1:200,814,250...200,917,581
|
|
G |
Lrp8 |
LDL receptor related protein 8 |
decreases expression |
ISO |
tanshinone results in decreased expression of LRP8 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
|
|
G |
Maob |
monoamine oxidase B |
increases expression |
ISO |
tanshinone results in increased expression of MAOB mRNA |
CTD |
PMID:15849732 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
decreases expression |
ISO |
tanshinone results in decreased expression of MAP3K1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:29906494 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:29906494 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mipep |
mitochondrial intermediate peptidase |
decreases expression |
ISO |
tanshinone results in decreased expression of MIPEP mRNA |
CTD |
PMID:15849732 |
|
NCBI chr15:34,926,198...35,051,722
Ensembl chr15:34,926,207...35,051,727
|
|
G |
Mir21 |
microRNA 21 |
multiple interactions |
ISO |
tanshinone inhibits the reaction [Particulate Matter results in increased expression of MIR21 protein] |
CTD |
PMID:35304817 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
tanshinone inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA] |
CTD |
PMID:30098273 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
[Doxorubicin co-treated with tanshinone] affects the expression of MMP2 protein; WAY-262611 affects the reaction [[Doxorubicin co-treated with tanshinone] affects the expression of MMP2 protein] |
CTD |
PMID:32886829 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
tanshinone results in decreased expression of MMP7 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
[Doxorubicin co-treated with tanshinone] affects the expression of MMP9 protein; tanshinone inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]; WAY-262611 affects the reaction [[Doxorubicin co-treated with tanshinone] affects the expression of MMP9 protein] |
CTD |
PMID:24929186 PMID:32886829 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msr1 |
macrophage scavenger receptor 1 |
decreases expression |
ISO |
tanshinone results in decreased expression of MSR1 mRNA |
CTD |
PMID:20854809 |
|
NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression |
ISO |
tanshinone results in increased expression of MYBL2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions |
ISO |
tanshinone results in decreased expression of MYC protein tanshinone results in decreased expression of MYC mRNA; tanshinone results in decreased expression of MYC protein [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of MYC mRNA]; [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of MYC protein]; [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in decreased expression of MYC mRNA]; [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in decreased expression of MYC protein] [Doxorubicin co-treated with tanshinone] affects the expression of MYC protein; WAY-262611 affects the reaction [[Doxorubicin co-treated with tanshinone] affects the expression of MYC protein] |
CTD |
PMID:16009009 PMID:18344322 PMID:21699893 PMID:32886829 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl1 |
myosin, light chain 1 |
increases expression |
ISO |
tanshinone results in increased expression of MYL1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 9:68,437,514...68,458,256
Ensembl chr 9:68,437,517...68,458,261
|
|
G |
Naa10 |
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
increases expression |
ISO |
tanshinone results in increased expression of NAA10 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr X:151,656,056...151,661,304
Ensembl chr X:151,656,056...151,661,252
|
|
G |
Nanog |
Nanog homeobox |
multiple interactions increases expression |
EXP ISO |
tanshinone inhibits the reaction [Estrogens deficiency results in decreased expression of NANOG protein] tanshinone results in increased expression of NANOG mRNA |
CTD |
PMID:25186638 PMID:31108107 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
ISO |
tanshinone results in increased expression of NDUFB2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
increases expression |
ISO |
tanshinone results in increased expression of NDUFV1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Nes |
nestin |
decreases expression |
ISO |
tanshinone results in decreased expression of NES mRNA; tanshinone results in decreased expression of NES protein |
CTD |
PMID:16955220 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA; [tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 protein; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in decreased expression of CDH1 protein]]; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in decreased expression of SMAD7 protein]]; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]]; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of FN1 protein]]; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 protein]]; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of VIM protein]]; NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased phosphorylation of SMAD3 protein]]; tanshinone promotes the reaction [Silicon Dioxide results in increased expression of NFE2L2 protein] [tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA; [tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 protein; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC2 mRNA]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC2 protein]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 mRNA]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of ABCC4 protein]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA]; NFE2L2 gene mutant form inhibits the reaction [[tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 protein]; tanshinone promotes the reaction [Acetaminophen results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:32097614 PMID:35243748 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
tanshinone inhibits the reaction [TNF protein results in decreased expression of NFKBIA protein] tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:29906494 PMID:30268796 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; tanshinone inhibits the reaction [Humic Substances results in increased expression of NOS2 protein]; tanshinone inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein] |
CTD |
PMID:23500011 PMID:24239652 PMID:29906494 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression multiple interactions |
ISO EXP |
tanshinone results in increased expression of NOS3 mRNA tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein] |
CTD |
PMID:15849732 PMID:28985491 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
ISO |
tanshinone results in decreased expression of NPPB protein |
CTD |
PMID:37643320 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
tanshinone promotes the reaction [Silicon Dioxide results in increased expression of NQO1 protein] |
CTD |
PMID:32097614 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
tanshinone results in increased activity of NR1I2 protein NR1I2 protein promotes the reaction [tanshinone results in increased expression of CYP3A4 protein] |
CTD |
PMID:18805405 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
NR1I3 protein affects the reaction [tanshinone results in increased expression of CYP3A4 protein] |
CTD |
PMID:18805405 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
NR3C1 protein affects the reaction [tanshinone results in increased expression of CYP3A4 protein] |
CTD |
PMID:18805405 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
decreases expression |
ISO |
tanshinone results in decreased expression of OLR1 mRNA; tanshinone results in decreased expression of OLR1 protein |
CTD |
PMID:22677363 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; DDIT3 mutant form inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; tanshinone promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; TNFSF10 protein promotes the reaction [tanshinone results in increased cleavage of PARP1 protein] |
CTD |
PMID:26203587 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp4 |
poly (ADP-ribose) polymerase family, member 4 |
increases expression |
ISO |
tanshinone results in increased expression of PARP4 mRNA |
CTD |
PMID:15849732 PMID:16955220 |
|
NCBI chr15:30,690,503...30,792,868
Ensembl chr15:30,686,613...30,828,810
|
|
G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
increases expression |
ISO |
tanshinone results in increased expression of PCSK7 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 8:46,202,079...46,224,699
Ensembl chr 8:46,202,131...46,224,705
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
increases expression multiple interactions |
EXP |
tanshinone results in increased expression of PHGDH mRNA tanshinone inhibits the reaction [Estrogens deficiency results in increased methylation of PHGDH promoter] |
CTD |
PMID:31108107 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
EXP |
Fulvestrant inhibits the reaction [tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased expression of PIK3R1 protein]]; tanshinone inhibits the reaction [IGF2 protein mutant form results in decreased expression of PIK3R1 protein] |
CTD |
PMID:34655285 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
decreases expression |
ISO |
tanshinone results in decreased expression of PLOD2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
increases expression multiple interactions |
ISO EXP |
tanshinone results in increased expression of POU5F1 mRNA tanshinone inhibits the reaction [Estrogens deficiency results in decreased expression of POU5F1 protein] |
CTD |
PMID:25186638 PMID:31108107 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
ISO |
tanshinone results in decreased expression of PPARG mRNA |
CTD |
PMID:20854809 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
multiple interactions |
EXP |
[Fulvestrant co-treated with tanshinone] promotes the reaction [IGF2 protein mutant form results in increased expression of PPP3CA protein]; tanshinone promotes the reaction [IGF2 protein mutant form results in increased expression of PPP3CA protein] |
CTD |
PMID:34655285 |
|
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Pram1 |
PML-RARA regulated adaptor molecule 1 |
multiple interactions |
ISO |
[tetraarsenic tetrasulfide co-treated with indirubin co-treated with tanshinone] results in increased ubiquitination of and results in increased degradation of PRAM1 protein |
CTD |
PMID:18344322 |
|
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
|
|
G |
Prpf6 |
pre-mRNA processing factor 6 |
decreases expression |
ISO |
tanshinone results in decreased expression of PRPF6 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 3:168,706,952...168,771,191
Ensembl chr 3:168,704,299...168,774,991
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
increases expression |
ISO |
tanshinone results in increased expression of PSMB5 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Psmd2 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
increases expression |
ISO |
tanshinone results in increased expression of PSMD2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
tanshinone inhibits the reaction [Humic Substances results in increased expression of PTGS2 protein]; tanshinone inhibits the reaction [lipoteichoic acid results in increased expression of PTGS2 protein] tanshinone inhibits the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein]; tanshinone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:22288910 PMID:23500011 PMID:24239652 PMID:24967690 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
decreases expression |
ISO |
tanshinone results in decreased expression of PTPRK mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
|
|
G |
Ptx3 |
pentraxin 3 |
decreases secretion multiple interactions decreases expression |
ISO |
tanshinone results in decreased secretion of PTX3 protein tanshinone inhibits the reaction [TNF protein results in increased expression of PTX3 mRNA]; tanshinone inhibits the reaction [TNF protein results in increased secretion of PTX3 protein] tanshinone results in decreased expression of PTX3 mRNA |
CTD |
PMID:30268796 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
|
|
G |
Rarb |
retinoic acid receptor, beta |
increases expression multiple interactions |
ISO |
tanshinone results in increased expression of RARB mRNA [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of RARB mRNA]; [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of RARB mRNA]; [tanshinone co-treated with indirubin] inhibits the reaction [RARB protein binds to HDAC1 protein]; [tetraarsenic tetrasulfide co-treated with tanshinone] inhibits the reaction [RARB protein binds to HDAC1 protein]; indirubin promotes the reaction [[tetraarsenic tetrasulfide co-treated with tanshinone] inhibits the reaction [RARB protein binds to HDAC1 protein]]; tetraarsenic tetrasulfide promotes the reaction [[tanshinone co-treated with indirubin] inhibits the reaction [RARB protein binds to HDAC1 protein]] |
CTD |
PMID:18344322 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions increases expression |
ISO |
[indirubin co-treated with tanshinone co-treated with tetraarsenic tetrasulfide] results in increased expression of RB1 protein; [indirubin co-treated with tanshinone co-treated with tetraarsenic tetrasulfide] results in increased phosphorylation of RB1 protein; [tanshinone co-treated with indirubin] results in increased expression of RB1 protein; [tanshinone co-treated with tetraarsenic tetrasulfide] results in increased expression of RB1 protein tanshinone results in increased expression of RB1 protein |
CTD |
PMID:18344322 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
tanshinone inhibits the reaction [TNF protein results in increased expression of RELA protein] |
CTD |
PMID:30268796 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoc |
ras homolog family member C |
increases expression |
ISO |
tanshinone results in increased expression of RHOC mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
|
|
G |
Sephs2 |
selenophosphate synthetase 2 |
increases expression |
ISO |
tanshinone results in increased expression of SEPHS2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased phosphorylation of SMAD3 protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:32097614 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad7 |
SMAD family member 7 |
multiple interactions |
ISO |
NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in decreased expression of SMAD7 protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in decreased expression of SMAD7 protein] |
CTD |
PMID:32097614 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
increases expression multiple interactions |
ISO EXP |
tanshinone results in increased expression of SOX2 mRNA tanshinone inhibits the reaction [Estrogens deficiency results in decreased expression of SOX2 protein] |
CTD |
PMID:25186638 PMID:31108107 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sp2 |
Sp2 transcription factor |
decreases expression |
ISO |
tanshinone results in decreased expression of SP2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:81,940,580...81,970,040
Ensembl chr10:81,940,587...81,970,548
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
EXP |
tanshinone inhibits the reaction [cobaltous chloride results in increased expression of SPP1 protein] |
CTD |
PMID:19356721 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
tanshinone inhibits the reaction [Particulate Matter results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:35304817 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tesk1 |
testis associated actin remodelling kinase 1 |
increases expression |
ISO |
tanshinone results in increased expression of TESK1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 5:57,691,922...57,697,698
Ensembl chr 5:57,691,969...57,697,698
|
|
G |
Tfap4 |
transcription factor AP-4 |
decreases expression |
ISO |
tanshinone results in decreased expression of TFAP4 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:11,001,338...11,019,386
Ensembl chr10:11,002,911...11,019,386
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions increases expression |
ISO |
NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 protein] tanshinone results in increased expression of TGFB1 protein |
CTD |
PMID:32097614 PMID:37643320 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tk1 |
thymidine kinase 1 |
increases expression |
ISO |
tanshinone results in increased expression of TK1 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; tanshinone inhibits the reaction [TNF protein results in decreased expression of NFKBIA protein]; tanshinone inhibits the reaction [TNF protein results in increased expression of PTX3 mRNA]; tanshinone inhibits the reaction [TNF protein results in increased expression of RELA protein]; tanshinone inhibits the reaction [TNF protein results in increased secretion of PTX3 protein] |
CTD |
PMID:29906494 PMID:30268796 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions increases response to substance |
ISO |
[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein; [TNFSF10 protein co-treated with tanshinone] results in increased expression of DDIT3 protein; [TNFSF10 protein co-treated with tanshinone] results in increased expression of TNFRSF10B protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; DDIT3 mutant form inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; DDIT3 mutant form inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased expression of TNFRSF10B protein]; tanshinone promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein]; tanshinone promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; TNFSF10 protein promotes the reaction [tanshinone results in increased cleavage of PARP1 protein] tanshinone results in increased susceptibility to TNFSF10 protein |
CTD |
PMID:26203587 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
increases expression decreases expression |
ISO |
tanshinone results in increased expression of TP53 protein tanshinone results in decreased expression of TP53 protein |
CTD |
PMID:16009009 PMID:19885617 PMID:20369472 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
tanshinone results in increased expression of VEGFA mRNA; tanshinone results in increased expression of VEGFA protein |
CTD |
PMID:25186638 PMID:37643320 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of VIM protein]]; tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of VIM protein] |
CTD |
PMID:32097614 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wfdc2 |
WAP four-disulfide core domain 2 |
increases expression |
ISO |
tanshinone results in increased expression of WFDC2 mRNA |
CTD |
PMID:15849732 |
|
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
|
|